Community Clinical Research Acquired By PhaseWell Research

PITTSBURGH, September 14, 2026 – The Braff Group is pleased to announce that its client, Community Clinical Research (“CCR”) in Austin, Texas, has joined PhaseWell Research (“PhaseWell”), a multisite clinical research company. CCR has established itself as one of the most experienced inpatient-capable CNS research sites in the country. The partnership advances PhaseWell’s mission of connecting communities to clinical trials, bringing hope today and shaping tomorrow’s medicine.

The Braff Group served as the exclusive financial advisor for Community Clinical Research. 

Community Clinical Research has built deep roots in Austin’s patient community through longstanding partnerships with providers, group homes, advocacy organizations, and clinical institutions across the region. CCR’s clinical team — led by Dr. Brown alongside Principal Investigator Dr. Samuel Collier, Sub-Investigator Reid Luedecke, PMHNP-BC and Mark Embry — brings deep expertise in both inpatient and outpatient CNS research, with the capability to match each study’s design and patient acuity to the appropriate setting. The site maintains a proprietary 25-year participant database of more than 1,200 prior participants and a referral network spanning more than 150 community organizations and is a preferred research provider across most major CROs with a consistent record of meeting 100 percent target enrollment on nearly all protocols it has conducted.

Headquartered in Nashville, Tennessee, PhaseWell Research is focused on increasing participation in clinical trials by offering innovative research opportunities within its trusted, high-performing sites and community practices nationwide. The addition of Community Clinical Research establishes the foundation of PhaseWell’s inpatient neuropsychiatric research capabilities, bringing a purpose-built, 24/7-staffed, 20-bed psychiatric research unit and the specialized infrastructure, deep psychiatric expertise, and operational experience to support complex CNS programs — particularly studies requiring intensive patient monitoring and inpatient execution.